The following data is part of a premarket notification filed by Acella Pharmaceuticals, Llc with the FDA for Loutrex Topical Cream.
Device ID | K120730 |
510k Number | K120730 |
Device Name: | LOUTREX TOPICAL CREAM |
Classification | Dressing, Wound, Drug |
Applicant | ACELLA PHARMACEUTICALS, LLC 248 LATITUDE LANE SUITE 104 Lake Wylie, SC 29710 |
Contact | Lara Noah |
Correspondent | Lara Noah ACELLA PHARMACEUTICALS, LLC 248 LATITUDE LANE SUITE 104 Lake Wylie, SC 29710 |
Product Code | FRO |
CFR Regulation Number | 510(k) Premarket Notification [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2012-03-09 |
Decision Date | 2012-09-06 |
Summary: | summary |